Thymopentin, also known as TP-5, is a synthesized derivative of thymopoietin, a
naturally occurring hormone responsible for inducing T-cell precursors to
differentiate and mature. A study at the Istituto di Patologia Medica in Bari,
Italy, reported thymopentin-related increases in T4 cells and some improvement
in symptoms for 21 people. Two studies of thymopentin published at the Sixth
International Conference on AIDS pointed to stabilization of T-helper counts and
p24 antigenemia in asymptomatic and mildly symptomatic patients during treatment
with thymopentin. One of the studies was too small to see differences in disease
progression. In the larger study, none of the treated patients progressed to
symptoms, compared to four of the placebo patients who did progress. No side
effects were attributed to thymopentin (http://www.aids.org/) A synthetic pentapeptide
which is the active site of the naturally occurring hormone thymopoietin with
immunomodulating properties. Thymopentin enhances the production of thymic T
cells and may help restore immunocompetence in immunosuppressed subjects. This
agent also augments the effects of ionizing radiation by arresting cancer cells
in the G2/M phase of the cell cycle.(http://www.cancer.gov/)
Thymopentin is a synthetic pentapeptide. It can modulate immune system.
Laboratories research and clinical results both show that it normalizes the
immune function in two directions (promoting or inhibiting) in various cases of
derangement, whether in suppression or hypersensitivity. Thus it is emerging as
an immune regulatory agent with great potential. Besides its activity in the
immune system, it was discovered to reduce the content of propane dialdehyde in
brain, thymus and liver, enhance the activity of SOD at the same moment of
improving its content, thus eliminate the radicals in human body and reduce the
level of lipid peroxides. All the above illuminate that it has affects against
aging and some circulatory system diseases.
(http://thymosin.net/) |